Journal of Pharmacy Practice and Research最新文献

{"title":"The structure and implementation of practice-integrated foundational professional development programs for hospital pharmacists: a scoping review","authors":"Yu Ting Sim BPharm,&nbsp;Saravana Kumar BAppSc (PT), GradDip (Digital Learning), MPT (Manip and Sports), PhD,&nbsp;Sally Marotti BPharm, MClinPharm, CGP,&nbsp;Carolyn Murray BAppSc (OT), MaOT, BHlthSc (Hons), PhD","doi":"10.1002/jppr.1964","DOIUrl":"https://doi.org/10.1002/jppr.1964","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Practice-integrated residency programs are one of the most recognised training platforms for early career development across settings, including hospital pharmacy. They embed a structured education and competency framework and preceptor mentoring systems in the workplace.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>This review aimed to map the global literature on practice-integrated education and professional development programs for early career hospital pharmacists, with a focus on how the programs were implemented and structured.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>A search was applied to electronic databases MEDLINE, Ovid Emcare, Embase, ERIC, Scopus, PsycINFO, Cochrane Library, Google Scholar and grey literature sources until 31 December 2023. Search terms were developed in consultation with an academic librarian and using the population, concept and context mnemonic. The scoping review was conducted and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews and the Joanna Briggs Institute scoping review manual.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Forty-seven papers were included from seven countries, with the majority (<i>n</i> = 33) being from the United States of America. Residency program details were mapped against jurisdictions and associated assessment processes, competency training areas, and focused training elements. Findings report similarities and differences of structural, competency frameworks, and locally driven context and requirements.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The demand from early career pharmacists for residency programs remains high, with professional pharmacy organisations providing leadership to grow training positions. The global pharmacy development goals appear to be embedded within the residency programs, but gaps include training in non-direct patient care competencies and research that demonstrates the outcomes from residency training.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"55 1","pages":"16-35"},"PeriodicalIF":1.0,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1964","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143424021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical pharmacy services supporting patient care","authors":"Michael J. Dooley BPharm, GradDipHospPharm, PhD, FSHP","doi":"10.1002/jppr.1968","DOIUrl":"https://doi.org/10.1002/jppr.1968","url":null,"abstract":"&lt;p&gt;In this issue of the &lt;i&gt;Journal of Pharmacy Practice and Research&lt;/i&gt; we have new Clinical Pharmacy Standards for the profession.&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt; It has been a pleasure to work alongside so many others to help bring this important consensus document together and to have been involved in the earlier versions. The first comprehensive standard of practice for clinical pharmacy was published by the Society of Hospital Pharmacists of Australia in 1996 with updated versions subsequently released in 2005 and 2015.&lt;span&gt;&lt;sup&gt;2-4&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;As practice has evolved over time the new &lt;i&gt;Advanced Pharmacy Australia Clinical Pharmacy Standards&lt;/i&gt;&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt; have been adapted to incorporate a greater focus on describing the key quality elements for practice as well as focus on person centred care and interdisciplinary practice whilst proving guidance on prioritisation of the clinical pharmacy services.&lt;/p&gt;&lt;p&gt;The accompanying editorial authored by Advanced Pharmacy Australia President Tom Simpson shares his views on the importance of this work and described the Standards as a blueprint for patient care and an ‘instruction manual’ for how to design, implement, and measure the clinical pharmacy services that underpin contemporary medicines management.&lt;span&gt;&lt;sup&gt;5&lt;/sup&gt;&lt;/span&gt; Dr Danielle McMullen, the President of the Australian Medical Association, describes the importance of collaboration between professions and the vision to implement innovative models of care safely, to improve patient outcomes and the experience as practitioner.&lt;span&gt;&lt;sup&gt;6&lt;/sup&gt;&lt;/span&gt; This perspective from our medical colleagues is vital as it reinforces one of the key principles in our Standards; that interprofessional collaboration is essential to the delivery of efficient and effective person-centred care.&lt;/p&gt;&lt;p&gt;These Standards provide a framework and guidance for comprehensive and accountable clinical pharmacy services. The underpinning principle is to describe current best practice to support the basic rights of patients when accessing healthcare services, including access, safety, respect, partnership, information, privacy, and the right to give feedback. Comprehensive and accountable clinical pharmacy services are an essential component of contemporary health care. The challenge has been to describe the quality of practice for clinical pharmacy services in Australia, irrespective of service type (private and public hospitals, inpatients, outpatients or community-based services) or location (metropolitan, regional, rural, or remote).&lt;/p&gt;&lt;p&gt;A fundamental component of these Standards has been to provide clear guidance for the pharmacy workforce, which encompasses pharmacists, but also includes pharmacy technicians and assistants who play a pivotal role in the care provided. The scope of practice and role delineation between the professional scope of practice of pharmacists and that of pharmacy technicians and assistants required significant considerat","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"54 6","pages":"439-440"},"PeriodicalIF":1.0,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1968","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143252579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Today's advanced is tomorrow's standard","authors":"Tom Simpson BPharm, FANZCAP (Lead&Mgmt), FAdPha","doi":"10.1002/jppr.1967","DOIUrl":"https://doi.org/10.1002/jppr.1967","url":null,"abstract":"&lt;p&gt;Our Society exists because our members collectively seek to ensure that patients receive the greatest benefit possible from the medicines with which they are treated.&lt;/p&gt;&lt;p&gt;This is reflected in the very first sentence of our Constitution: “[t]he overriding purpose of the Society is to improve health outcomes from medicines use within hospitals and/or other healthcare facilities or settings (including the home) where pharmacists, the membership and other health professionals practice, through the use of pharmacist expertise in medicine management”.&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt;&lt;sup&gt;(p1)&lt;/sup&gt;&lt;/p&gt;&lt;p&gt;If this statement is the &lt;i&gt;why&lt;/i&gt;, the &lt;i&gt;Advanced Pharmacy Australia Clinical Pharmacy Standards&lt;/i&gt; are the &lt;i&gt;how&lt;/i&gt;.&lt;/p&gt;&lt;p&gt;The breadth of Advanced Pharmacy Australia's (AdPha's) Clinical Pharmacy Standards spans every element of the Australian health system in which patients, pharmacy practitioners, and medicines intersect and interact. Although it may appear to be a paradox, the Standards are both a foundation and a nexus point.&lt;/p&gt;&lt;p&gt;AdPha's Clinical Pharmacy Standards are a foundation because they are agnostic of care setting. Whether on a ward, in aged care, general practice, or at home, the person receiving care is wrapped in individual patient care activities, which blend into the interprofessional practice that ensures multidisciplinary input into evidence-based decisions. This is depicted in the concentric circles of the &lt;Figure 1: Clinical pharmacy services&gt;.&lt;span&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;Surrounding this person-centred care are three enablers: prioritisation to maximise impact; a skilled workforce; and innovation that ensures patients benefit from new approaches to care.&lt;/p&gt;&lt;p&gt;At the same time, the Standards are a nexus. The &lt;Figure 1: Clinical pharmacy standards&gt; shows the principles that wrap around the patient consistently, through all-important transitions of care.&lt;span&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;As well as a blueprint for patient care, the Standards represent an ‘instruction manual’ for how to design, implement, and measure the clinical pharmacy services that underpin contemporary medication management.&lt;/p&gt;&lt;p&gt;It is noteworthy this is achieved with a distinctly Australian flavour, reflecting our health system that is unique in the world. Around four-fifths of the references upon which the Standards are built are Australian, including 25 references to articles published in this journal, AdPha's flagship academic publication.&lt;span&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt; This reflects the deep expertise of our members and their contribution to evidence of pharmacy impact, nationally and globally.&lt;/p&gt;&lt;p&gt;The maturity of practice they represent is also noteworthy. The 2024 Standards don't only focus on what clinical pharmacy &lt;i&gt;is&lt;/i&gt;, but on the entire supporting system that equips practitioners for the settings in which they practice.&lt;/p&gt;&lt;p&gt;The Standards link deeply with the Australian and New Zealand College of Advanced Pharmacy (ANZCAP), AdPha'","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"54 6","pages":"441-443"},"PeriodicalIF":1.0,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1967","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143252580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Resilience and strength in healthcare standards","authors":"Dr Danielle McMullen MBBS (Hons), FRACGP, DCH","doi":"10.1002/jppr.1966","DOIUrl":"https://doi.org/10.1002/jppr.1966","url":null,"abstract":"&lt;p&gt;Standards exist at many levels with many objectives in healthcare and are essential to the work we do as health care professionals.&lt;/p&gt;&lt;p&gt;Across professions and in all settings, high-quality, enforceable standards mean that I know my colleagues have at least met basic standards in their training and education, the service I am working in meets required safety standards, and the tools I use have met the relevant standards.&lt;/p&gt;&lt;p&gt;I know from personal experience meeting all accreditation standards in a general practice requires consistent and deliberate effort, but we do this because it upholds patient safety and supports the best outcomes.&lt;/p&gt;&lt;p&gt;The launch of the revised Advanced Pharmacy &lt;i&gt;Australia Clinical Pharmacy Standards&lt;/i&gt;&lt;span&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/span&gt; is a positive contribution to our health system and to driving collaboration between professions.&lt;/p&gt;&lt;p&gt;Despite this, the Australian Medical Association (AMA) is deeply concerned standards in healthcare are under threat.&lt;/p&gt;&lt;p&gt;The challenge to standards we currently face is a political one. Australia is suffering serious health workforce pressures which are experienced by the public as delayed access and by health professionals as increased pressure and often expectations to do more with less. Lowering standards to facilitate workforce growth is an appealing solution, but not the right one.&lt;/p&gt;&lt;p&gt;Despite our current workforce shortages, Australia continues to have one of the best health systems in the world. The most recent report from the Commonwealth Fund comparing the health systems of 10 wealthy, developed nations ranked Australia's system as the best overall and the best in health outcomes.&lt;span&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt; Rigorous standards in safety, accreditation, education, and training contribute to these outcomes.&lt;/p&gt;&lt;p&gt;Australia performed far worse in terms of access, ranking ninth.&lt;span&gt;&lt;sup&gt;2&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;The challenge before us as health professionals is to resist lowering standards to improve access. Lowering standards puts positive health outcomes at risk. We have seen this threat to standards proposed as a solution in successive reviews driven largely by the health ministers' meeting. Notably, the recent &lt;i&gt;Independent review of Australia's regulatory settings relating to overseas health practitioners&lt;/i&gt; (known as the ‘Kruk Review’) has proposed lowering English language standards and introducing a new pathway for specialist international medical graduates to register in Australia outside the control of the medical colleges.&lt;span&gt;&lt;sup&gt;3&lt;/sup&gt;&lt;/span&gt;&lt;/p&gt;&lt;p&gt;The specialist medical colleges are responsible for ensuring their training programs develop medical professionals who can demonstrate clinical competence and meet patient expectations. The training programs provided by these colleges are comprehensive, involving a strong emphasis on evidence-based medicine, patient safety, and clinical decision-making. Importantly, the programs are designed for the Australian health system ","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"54 6","pages":"444-445"},"PeriodicalIF":1.0,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1966","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143252581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Advanced Pharmacy Australia Clinical Pharmacy Standards","authors":"Michael Dooley BPharm, GradDipHospPharm, PhD, FANZCAP (Lead&Mgmt), FSHP,&nbsp;Georgia Bennett BPharm (Hons), ANZCAP-Reg (OncHaem), AdPhaM,&nbsp;Tara Clayson-Fisher GCertClinLead, FANZCAP (Lead&Mgmt), FAdPha,&nbsp;Courtney Hill BPharm, ProfHonsClinPharm, GradCertClinicalResdesign, FANZCAP (Lead&Mgmt, Generalist), AdPhaM,&nbsp;Neil Lam BPharm, MMedSci (Drug Dev) BCGP, ANZCAP-Reg. (OncHaem), AdPhaM,&nbsp;Sally Marotti BPharm, MClinPharm, FANZCAP (Edu., Research), FAdPha,&nbsp;Kate O'Hara BMedSci (Hons), MPharm, PhD, FANZCAP (Neonatol., Paeds), AdPhaM,&nbsp;Cassandra Potts BPharm, GradCertChronCondMgt, FANZCAP (Cardiol.), AdPhaM,&nbsp;Brenda Shum BSc (Hons), BPharm, MBA (Health Management), FANZCAP (Lead&Mgmt), GAICD, FAdPha,&nbsp;Erica Tong BPharm (Hons), MClinPharm, PhD, CHIA, FANZCAP (Informatcs, GenMed), FAIDH, FSHP,&nbsp;Susan Trevillian BPharm, PGradDipHospPharm, FANZCAP (Lead&Mgmt, RuralHlth), FAdPha,&nbsp;Nick Sharp-Paul BA, PGDipArts (Edit&Comm),&nbsp;Suzanne Newman BPharm, GradDipHospPharm, ANZCAP-Reg. (Generalist), AdPhaM,&nbsp;Yee Mellor BPharm, MCncrSc, FANZCAP (Edu., Generalist), AdPhaM","doi":"10.1002/jppr.1959","DOIUrl":"https://doi.org/10.1002/jppr.1959","url":null,"abstract":"","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"54 6","pages":"446-511"},"PeriodicalIF":1.0,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143252562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Fibrinogen concentrate use in the operating theatre at a quaternary hospital in Australia","authors":"Kate Elizabeth Doreen Ziser BPharm, GradDipEd, MClinPharm,&nbsp;Madeline Bullock BPharm,&nbsp;Brett Coghill BPharm (Hons),&nbsp;Sarah Al-Kureshy BPharm (Hons),&nbsp;Aaron Nihal MD, BMedSt,&nbsp;Jess Bendeich BNurs","doi":"10.1002/jppr.1947","DOIUrl":"https://doi.org/10.1002/jppr.1947","url":null,"abstract":"<p>At our quaternary teaching hospital in Queensland, Australia, there has been a rapid increase from 2019 to 2022 in the usage of fibrinogen concentrate (FC) in preference to cryoprecipitate for cardiac surgery. FC is indicated for patients having major trauma requiring haemostatic resuscitation, major intraoperative haemorrhage, or liver transplant patients with major intraoperative haemorrhage. These patients must exhibit severe hypofibrinogenaemia, which is assessed using assay cut-offs of thromboelastogram (TEG) (citrated functional fibrinogen [CFF] ≤ 10 mm) or rotational thromboelastometry (ROTEM) (FIBTEM A5 ≤ 8 mm). FC usage over cryoprecipitate for cardiac surgery is an ongoing debate due to advantages such as dose predictability, rapid reconstitution, viral inactivation, and minimal transfusion-related adverse events; however, it is expensive. The aim of this study was to capture prescribing patterns of FC and appropriateness against local guidelines. Retrospective data were analysed, and the practice was compared to hospital guidelines. Data from 52 patients over a 4-year period (2019–2022) showed intraoperative haemorrhage was the leading indication for FC use (65%, <i>n</i> = 34), followed by liver transplantation (27%, <i>n</i> = 14), and major trauma (8%, <i>n</i> = 4). When breaking down the cause of intraoperative haemorrhage, cardiothoracic surgery, both elective (50%, <i>n</i> = 17) and emergency procedures (41%, <i>n</i> = 14), accounted for 91% of all operative bleeding requiring FC. There were 34 (65%) of 52 patients who received a differing dose of FC compared to what was recommended in the hospital guideline, with 50% (<i>n</i> = 17) receiving a higher than recommended dose and 50% (<i>n</i> = 17) receiving lower than recommended doses. This project was exempt due to the local policy requirements that constitute research by the Metro South Human Research Ethics Committee (Reference no: CM2305202303). The justification for this exemption was as follows: the study presented no foreseeable risk of patient harm as it involved evaluation of standard care involved the use of existing non-identifiable patient records.</p>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"55 1","pages":"79-84"},"PeriodicalIF":1.0,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1947","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143423580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Standard of practice for pharmacy services specialising in transitions of care","authors":"Katie Phillips BPharm (Hons), GradCertPharmPract, FANZCAP (ToC, PrimCare), AcSHP, MPS, AdPhaM,&nbsp;Deirdre Criddle BPharm, GradDipHospPharm, FANZCAP (ToC, GeriMed), AcSHP, FPS, FSHP,&nbsp;Margaret Jordan BPharm, MSc (Res), PhD, FANZCAP (MedsMgmt, PrimCare) AcSHP, FSHP,&nbsp;Elizabeth Manias RN, BPharm, MPharm, PhD, BCGP, MPS, FANZCAP (ToC, GeriMed), AdPhaM,&nbsp;Brigid McInerney BPharm, MClinPharm, FANZCAP (ToC, GeriMed), AcSHP, AdPhaM,&nbsp;Horst Thiele DiplPharm, AdPhaM,&nbsp;Ahmed Zeidan BPharm, GCeH, MClinPharm, BCGP, FANZCAP (ToC, GeriMed), AdPhaM,&nbsp;Yee Mellor BPharm, MCncrSc, FANZCAP (Edu., Generalist), AdPhaM","doi":"10.1002/jppr.1957","DOIUrl":"https://doi.org/10.1002/jppr.1957","url":null,"abstract":"","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"54 5","pages":"417-435"},"PeriodicalIF":1.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142664564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Australian Injectable Drugs Handbook (AIDH): Experience of artificial intelligence translations of non-English product information","authors":"Emma Wong BPharm, GradDipHospPharm, FANZCAP (Emerg),&nbsp;Keli Symons BPharm, AACPA, FANZCAP (GeriMed, PrimCare)","doi":"10.1002/jppr.1946","DOIUrl":"https://doi.org/10.1002/jppr.1946","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>In June 2022, the Society of Hospital Pharmacists of Australia (SHPA) Specialty Practice Medicines Information Leadership Committee formally requested an expanded range of imported medicines to be included in the latest edition of the <i>Australian Injectable Drugs Handbook</i> (AIDH), developed and published by SHPA. This request was to aid medication safety and reduce the duplication of work required by tertiary hospital staff when producing local guidance. This study describes the challenges faced by the AIDH editorial team in obtaining information in English for imported medicines.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>The purpose of this study was to determine whether machine translation is suitable for translating foreign language product information (PI) documents into English.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>Three sources (one machine and two human sources) were used to translate the PI provided for five imported medicines from four languages into English. We compared the quality of the translations for obtaining information suitable to inform a medicine administration guideline. Ethical approval was not required for this research article as it involved no experimental investigations on humans and did not involve human participants or cohort comparisons.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Our study found machine translation and human translations to be very similar in terms of readability and adequacy. Machine translation was found to be more time-saving and cost-effective.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Our results suggest that it may be appropriate for pharmacists to harness the time- and cost-saving benefits of machine translation. However, pharmacists must apply their critical evaluation skills to the information provided regardless of the source of the translation. Information translated from another language relating to the administration of an injectable medicine must be verified against an English language source.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"55 1","pages":"68-78"},"PeriodicalIF":1.0,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143423930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Scoping the barriers to influenza and pneumococcal vaccinations from the perspectives of patients with cancer: is there a role for the pharmacist?","authors":"Kristoffer Johnstone BPharm, GDPHTM, MSHP, FANZCAP (OncHaem),&nbsp;John Smithson BNSc, BPharm, PhD,&nbsp;Joyce Cooper PhD, BSc (Pharmacy), GDCLinPharm, GCClinEpi, GCTertiaryTeach, FSHP,&nbsp;Beverley Glass BPharm, BSc (Chemistry), PhD, ARPharmS, FPS","doi":"10.1002/jppr.1940","DOIUrl":"https://doi.org/10.1002/jppr.1940","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Routine immunisation for influenza and pneumococcal disease has the potential to reduce morbidity and mortality in patients with cancer.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>This scoping review aims to determine barriers to influenza and pneumococcal vaccinations from the perspective of patients with cancer and to discuss the potential role of the pharmacist in impacting these barriers.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Design</h3>\u0000 \u0000 <p>A systematic search of seven databases, including MEDLINE (Ovid), Cochrane Library, Informit (health), PubMed, and CINAHL (complete), from database inception to 6 June 2023 was conducted. Search terms included: 'cancer', 'vaccination', 'influenza', 'pneumococcal', and 'barrier'. Articles published in English that describe barriers to receiving vaccinations from the perspectives of patients with cancers were included. Barriers were thematically analysed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Twenty-five articles met the inclusion criteria. Barriers identified in the literature were analysed into three key themes: healthcare professionals, patients, and healthcare system barriers. A key healthcare professional barrier was lack of recommendations from the treating oncologist or haematologist. Patient barriers included lack of information about the indication for vaccination as part of patients' cancer treatment and fear of side effects. Access to vaccination services was reported as a healthcare system barrier.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This scoping review highlights the significant barriers to influenza and pneumococcal vaccination according to patients with cancer. Healthcare professionals, patients, and health systems were identified as key barriers. Enablers to improve vaccination rates include patient education, increased healthcare professional vaccine recommendations, and improved access. Although pharmacists have a potential role to play in addressing these barriers, the feasibility and impact of their involvement requires further research.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"55 1","pages":"1-15"},"PeriodicalIF":1.0,"publicationDate":"2024-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1940","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143423566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessment of enoxaparin-related knowledge, administration technique, and self-reported adherence among women after caesarean section delivery","authors":"Sutha Rajakumar BPharm,&nbsp;Retha Rajah PhD,&nbsp;Nur Alia Razali BPharm,&nbsp;Tan Xin Yan BPharm,&nbsp;Ooi Guat Tee BPharm","doi":"10.1002/jppr.1943","DOIUrl":"https://doi.org/10.1002/jppr.1943","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Venous thromboembolism is among the main causes of maternal morbidity and mortality, with caesarean section (CS) delivery carrying greater risk. Outpatient thromboprophylaxis, such as enoxaparin, is administered subcutaneously and prescribed as an outpatient; raising the issue of medication adherence.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>This study aimed to evaluate women's adherence to enoxaparin administration after CS delivery, explore the reasons for non-adherence, and assess the factors associated with patients' adherence to enoxaparin.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Method</h3>\u0000 \u0000 <p>Women after CS delivery, who had been given enoxaparin at discharge were included in the study. Eligible patients were contacted via telephone at the middle and the end of the enoxaparin treatment. Syringe count determined the main outcome of adherence during direct telephone interviews with the patient. Optimal adherence was defined as all the doses of enoxaparin being administered and suboptimal adherence was at least one dose not administered. Ethical approval was granted by the Malaysian Registry Ethics Committee belonging to National Medical Research Registry (Reference no: NMRR ID-22-02859-P41) and the study conforms with the Declaration of Helsinki. Informed consent was obtained from all participants through completion of written consent forms, after an explanation of the study was provided by investigators.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Out of 201 women included, the majority (91.5%) were fully adherent to enoxaparin, while 8.5% missed at least one dose. Most patients administering at home missed the dose due to reporting they were unwell (<i>n</i> = 6), busy (<i>n</i> = 4), or forgot to administer (<i>n</i> = 2). Among missed doses in patients administered in a healthcare setting, all participants (<i>n</i> = 5) forgot to bring their medication to the appointment. Only medication knowledge had a significant association with adherence to enoxaparin administration (p = 0.008).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The study raised concern about the substantial percentage of patients missing at least one dose of enoxaparin, particularly among patients injecting at home. Initiatives should focus on customised enoxaparin administration counselling and providing educational materials.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":"55 1","pages":"61-67"},"PeriodicalIF":1.0,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/jppr.1943","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143424324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}